Product Information
AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.2640 per EA under NDC 23155084403. Its NADAC has been published 169 times since Jul 12, 2023.
FDA first approved this application on Mar 28, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 160 mg/1; mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155084403
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA090011FDA Approved
3/28/2013
TE Code
AB
On Market Since
3/15/2023
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 169 times since Jul 12, 2023, and over the history we have for it it has declined 46.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2640 per EA |
|---|---|
| All-time high | $0.5159 (Apr 10, 2024) |
| All-time low | $0.2640 (Sep 23, 2026) |
| 52-week high | $0.4755 |
| 52-week low | $0.2640 |
| Median price | $0.4641 |
| Average price | $0.4461 |
| Largest weekly change | +35.2% (Aug 21, 2024) |
| Weeks tracked | 169 |
| Tracking since | Jul 12, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine and valsartan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Heritage Pharmaceuticals Inc., is $0.2640 per EA (NDC 23155084403), effective Sep 30, 2026.
How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 46.9%. It has been tracked across 169 weekly CMS publications since Jul 12, 2023.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?
Since Jul 12, 2023, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.2640 (Sep 23, 2026) to a high of $0.5159 (Apr 10, 2024), with a median of $0.4641 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 5-160 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?
AMLODIPINE-VALSARTAN 5-160 MG (NDC 23155084403) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.